Duopharma Biotech Berhad (KLSE:DPHARMA)
1.030
-0.050 (-4.63%)
At close: Nov 20, 2026
| Market Cap | 990.80M -18.3% |
| Revenue (ttm) | 916.98M +1.8% |
| Net Income | 107.61M +28.9% |
| EPS | 0.11 +28.9% |
| Shares Out | 961.94M |
| PE Ratio | 9.20 |
| Forward PE | 9.18 |
| Dividend | 0.05 (4.42%) |
| Ex-Dividend Date | Sep 3, 2026 |
| Volume | 882,700 |
| Open | 1.080 |
| Previous Close | 1.080 |
| Day's Range | 1.000 - 1.090 |
| 52-Week Range | 1.030 - 1.570 |
| Beta | 0.38 |
| Analysts | Strong Buy |
| Price Target | 1.67 (+61.75%) |
| Est. Earnings | Feb 23, 2027 |